跳至主要内容
临床试验/CTRI/2025/02/081030
CTRI/2025/02/081030尚未招募不适用

ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE Vs FOLLICULINUM IN MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME

Dr Soni Devi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To determine whether there is a significant difference between the effectiveness of

研究概览

简要总结

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women, affecting approximately 5% to 20% of women of reproductive age.It is characterized by hormonal imbalances, irregular menstrual cycles, and metabolic disturbances. A recent study found that PCOS was the most common underlying etiology in adolescents hospitalized with abnormal uterine bleeding (AUB) and menorrhagia, accounting for 33% of admissions. Homoeopathy, an individualized system of medicine offers a holistic approach to treating PCOS by addressing the unique system patterns presented by each patient. In homoeopathy, repertories serve as essential tools to identify similimum remedies that best match of totality of symptoms. In the cases in which PCOS causes infertility, FOLLICULINUM medicine improve the quality of eggs and helpful in managing the infertility. A comparative study between individualized homoeopathic medicine and Folliculinum can help establish the efficacy of these treatments in PCOS managemen’This study can provide insights into the most effective personalized treatment approach for PCOS patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • 1 Women between age of 18 to 35 years 2 Married & Unmarried females 3 Diagnosed cases of PCOS according to Rotterdam criteria 2003 Criteria should include two of the following three criteria Chronic anovulation Hyperandrogenism Polycystic ovaries 4 Body Mass Index BMI between 18.5 – 40 kg/m2 5 Participants willing to adopt healthy diet and to take regular exercise at least 30 minutes of exercise for at least 5 days a week 6 Patients with ability to give informed consent with comply with study.

排除标准

  • 1 Pregnant and lactating women 2 Below the age of 18 and above the age of 35 years 3 Women with other hormonal disorders example Cushing syndrome congenital adrenal hyperplasia 4 Women taking hormonal medicines Birth control pills fertility medicine 5 History of intake of drugs Aldactone/Metformin or history of oral pills OCP use or intake of drugs known to interfere with carbohydrate metabolism 4 weeks prior to enrollment 6 Cases with any systemic disease HTN DM Thyroid or any Immune Suppressive Disease 7 Patients who can not make regular follow up.

结局指标

主要结局

To determine whether there is a significant difference between the effectiveness of

时间窗: 6 months

Folliculinum and Individualized Homoeopathic Medicine in PCOS Management.

时间窗: 6 months

次要结局

  • To access the condition of ovaries by pelvic USG and the Modified Naranjo Criteria for Homoeopathy (MONARCH) to access the likelihood of casual relationship between Homoeopathic Medicine and clinical outcome.(6 months)

研究者

发起方
Dr Soni Devi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Soni Devi

State National Homoeopathic Medical College and Hospital lucknow

研究点 (1)

Loading locations...

相似试验

INDIVIDUALIZED HOMOEOPATHIC MEDICINE Vs FOLLICULINUM... | 临床试验